The Russian Society of Clinical Oncology was headed by the head of the oncology department of antitumor drug therapy of the Central Clinical Hospital of the Administration of the President of the Russian Federation, Dmitry Nosov. The candidacy of the new chairman was approved by the members of the board.
From November, one of the largest professional communities in the country – the Russian Society of Clinical Oncology (RUSSCO) will be headed by the head of the oncology department of antitumor drug therapy of the Central Clinical Hospital with the clinic of the Administration of the President of the Russian Federation, professor of the Russian Academy of Sciences Dmitry Nosov. As the organization told MV, his candidacy was approved by 25 board members.
Former Chairman of RUSSCO Professor resigned, he remains a member of the board of the company.
Dmitry Nosov is the head of the expert committee for the development of clinical recommendations of RUSSCO, a member of the expert council of the Higher Attestation Commission of the Ministry of Education and Science. From 1995 to 2016 he worked at the National Medical Research Center of Oncology named after. N.N. Blokhina. Full member of the European Society of Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). In 2002-2008 he was the national representative of Russia in ESMO.
— one of the founders of RUSSCO, served as chairman of the organization since 2012. Previously, he resigned from the post of Deputy Director of the Research Institute of Clinical Oncology for scientific work of the National Medical Research Center of Oncology named after. N.N. Blokhin and the head of the department of clinical pharmacology and chemotherapy, wrote “MV”. The scientist explained his decision by his age and desire to engage in science.